clinical trial · NCT06807762
Safety and Pharmacokinetics of Extrato de Cannabis Sativa GreenCare
GreenCare Pharma·phase1·recruiting·n = 72
HealthyCannabis oil
brief summary
The goal of this Phase I clinical trial is to assess the pharmacokinetic availability and safety and tolerability profile of Extrato de Cannabis sativa GreenCare 79.14 mg/mL. The main question it aims to answer is: • Is the Extrato de Cannabis sativa GreenCare 79,14 mg/mL safe?
started
Mar 18, 2025
primary completion
Jun 1, 2025
completion
Dec 1, 2025
last updated
Mar 21, 2025
official title
Phase I Clinical Trial to Assess Tolerability, Safety, and Pharmacokinetics of Extrato de Cannabis Sativa GreenCare 79.14 mg/mL - Drops Solution - in Healthy Research Participants of Both Sexes in a Fed State
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol